跳至主要内容
临床试验/ACTRN12620000143921
ACTRN12620000143921尚未招募未知

A pilot randomized controlled trial assessing the gastrointestinal tolerability and health benefits of Soluble Tapioca Fibre in adults with healthy gastrointestinal systems: Phase Two

Murdoch University0 个研究点目标入组 60 人开始时间: 2020年2月12日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Individuals without clinically diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility and agree to keep a detailed dietary for GI symptoms and stool characteristics during the study. In addition, potential participants will be required to complete Phase One of the study to be eligible for participation in Phase Two of the study.

排除标准

  • Individuals having constipation, defined as 0–3 stools per week for the last 6 weeks; prescription of medication for digestive symptoms such as anti-spasmodic, laxatives, anti-diarrheic drugs or other digestive auxiliaries, relevant history/presence of any medical disorder or intake of medication/dietary supplements potentially interfering with this trial (e.g. irritable bowel syndrome), vegetarians or vegans, intake of antibiotics within 4 weeks before the screening visit and intake of laxatives within 2 weeks before the screening visit.

研究者

相似试验

Assessing the tolerability and health benefits of... | 临床试验